| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |